Koers MDxHealth SA Euronext Bruxelles
Aandelen
MDXH
BE0974461940
Biotechnologie & Medisch Onderzoek
Omzet 2023 | 64,39 mln. 68,49 mln. | Omzet 2024 * | 73,53 mln. 78,21 mln. | Marktkapitalisatie | 58,68 mln. 62,42 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -39 mln. -41,48 mln. | Nettowinst (verlies) 2024 * | -26 mln. -27,66 mln. | EV/omzet 2023 | 1,51 x |
Nettoliquiditeiten 2023 * | - 0 | Nettoliquiditeiten 2024 * | - 0 | EV/omzet 2024 * | 0,8 x |
K/w-verhouding 2023 |
-2,37
x | K/w-verhouding 2024 * |
-2,29
x | Werknemers | 255 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 97,37% |
Recentste transcriptie over MDxHealth SA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,82% | 41,36 mld. | |
+44,25% | 41,3 mld. | |
+2,56% | 39,61 mld. | |
-12,11% | 25,62 mld. | |
+3,09% | 24,09 mld. | |
-24,16% | 18,38 mld. | |
+22,12% | 11,85 mld. | |
-3,74% | 11,82 mld. | |
+7,75% | 11,07 mld. |